PB2158 POMALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (PCD) IS AN EFFECTIVE SALVAGE REGIMEN FOR MULTIPLE MYELOMA (MM) PATIENTS RELAPSED ON OR REFRACTORY TO DARATUMUMAB

Autor:	Inken Hilgendorf, Thomas Ernst, Annamaria Brioli, F. Hunstig, Andreas Hochhaus, Florian H. Heidel, M. von Lilienfeld-Toal
Rok vydání:	2019
Předmět:	Oncology medicine.medical_specialty Cyclophosphamide business.industry Daratumumab Hematology Pomalidomide medicine.disease Refractory Internal medicine Salvage regimen medicine business Dexamethasone Multiple myeloma medicine.drug
Zdroj:	HemaSphere. 3:970
ISSN:	2572-9241
DOI:	10.1097/01.hs9.0000567116.70967.37
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::bb5c093f8488791da42d3f15d229ef55 https://doi.org/10.1097/01.hs9.0000567116.70967.37 Zobrazit plný text záznamu Plný text